Dave's transparent fees and robust growth drive its outlook, yet high borrowing costs and valuation risks prompt a cautious ...

It’s one of the most explosive sectors in the market — but also one of the riskiest. Biotech investors, beware. Small-cap biotech stocks can be extremely volatile… but if you know what to look for, ...